Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: Results of a retrospective survey and evaluation of the validity of a medical information system programme

Epidemiology and Infection

Volumn 140, Issue 4, 2012, Pages 608-616

  Soilly, A L ^a,b   Ferdynus, C ^a   Desplanches, O ^a   Grimaldi, M ^a,c   Gouyon, J B ^a,c  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Bronchiolitis; paediatric intensive care unit; prematurity; respiratory syncytial virus

Indexed keywords

CHILD; CHILD HOSPITALIZATION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; EPIDEMIC; FEMALE; FRANCE; HOSPITAL ADMISSION; HUMAN; INFANT; INFANT MORTALITY; INTENSIVE CARE UNIT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; NONINVASIVE VENTILATION; OXYGEN THERAPY; PREMATURITY; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; REVIEW; SEASONAL VARIATION; VIRAL BRONCHIOLITIS;

BRONCHIOLITIS, VIRAL; DATABASES, FACTUAL; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; REPRODUCIBILITY OF RESULTS; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RETROSPECTIVE STUDIES;

EID: 84858048706     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811001208     Document Type: Review

References (21)

1. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Archives of Disease in Childhood 2003; 88: 1065-1069. (Pubitemid 38064480)
2. Hall CB. Respiratory syncytial virus and parainfluenza virus. New England Journal of Medicine 2001; 344: 1917-1928. (Pubitemid 32553362)
3. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. Journal of Pediatrics 2003; 143 (Suppl.): S127-S132. (Pubitemid 37456910)
4. American Academy of Pediatrics. Committee of Infectious Diseases. Policy statements - modified recommen ations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009; 124: 1694-1701.
5. Grimprel E. Epidemiology of infant bronchiolitis in France [in French]. Archives de Pédiatrie 2001; 8 (Suppl.1): 83-92. (Pubitemid 33713589)
6. Agency for Information on Hospital Care. Methodological guide for the production of PMSI summaries of hospital stays in medicine, surgery and obstetrics. Annex III of the Order of 31 December 2003 as amended by the Decree of 28 February 2006 [in French]. (http://www.atih.sante.fr/index.php?id= 000240007EFF).
7. Quantin C, et al. Methodology for the linkage of sensitive data while preserving anonymity: Application to the monitoring of medical information [in French]. Courrier des statistiques no. 113-114 - Dossier spé cial panel et appariements sécurisé s ' - 2005, pp. 39-52.
8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1997; 33: 159-174.
9. Ferdynus C, et al. Can birth weight standards based on healthy populations improve the identification of small-for-gestational-age newborns at risk of adverse neonatal outcomes? Pediatrics 2009; 123: 723-730.
10. Berger TM, et al. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005). Infection 2009; 37: 109-116.
11. Feltes TF, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically congenital heart disease. Journal of Pediatrics 2003; 143: 532-540. (Pubitemid 37352516)
12. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Archives of Disease in Childhood 2009; 94: 99-103.
13. Navas L, et al. Improved outcome of respiratory syncytial virus infection in high-risk hospitalized population of Canadian children. Pediatric investigators collaborative network on infections in Canada. Journal of Pediatrics 1992; 121: 348-354.
14. Moler FW, et al. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience. Critical Care of Medicine 1992; 20: 1406-1413.
15. Prais D, Schonfeld T, Amir J. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: A national survey before palavizumab use. Pediatrics 2003; 112: 548-552. (Pubitemid 37082105)
16. Grimaldi M, Cornet B, Milou C. Regional prospective study of an epidemic of respiratory syncytial virus bronchiolitis (RSV) [in French]. Archives de Pédiatribe 2002; 9: 572-580. (Pubitemid 34650842)
17. Eriksson M, et al. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatrica 2002; 91: 593-598. (Pubitemid 34620649)
18. Hernando Puente M, et al. Prognostic factors for complications in bronchiolitis requiring admission to paediatric intensive care [in Spanish]. Anales de Pediatria (Barcelona) 2009; 70: 27-33.
19. Cilla G, et al. Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain. Epidemiology and Infection 2006; 134: 506-513.
20. Chevret L, et al. Bronchiolitis in paediatric intensive care unit: prognostic factors and respiratory outcome of ventilated infants [in French]. Archives de Pédiatribe 2005; 12: 385-390.
21. Hascoet JM, et al. Methodological aspects of economic evaluation of paediatric drug: The example of RSV infection prophylaxis in France [in French]. Archives de Pédiatrie 2008; 15: 1739-1748.